Fundz

Elevation Oncology, Inc. reported raising $65 Million in an initial SEC Form D filing, from an offering of $65 Million

PRIVATENov 18, 2020

Amount Raised

$65 Million

$65 Million sold, per SEC Form D (first sale Nov 18, 2020)

Round Type

Venture

BostonBiotechnologyHealthcareHealth CareMedicalGeneticsTherapeutics

Quick answer

Elevation Oncology raised $65 Million in a funding round, dated November 18, 2020. Elevation Oncology is based in Boston, Massachusetts, United States.

How much did Elevation Oncology raise?
Elevation Oncology raised $65 Million in a funding round on November 18, 2020.
What does Elevation Oncology do?
Elevation Oncology is founded on the belief that every patient living with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it.
Where is Elevation Oncology based and how big is it?
Elevation Oncology is based in Boston, Massachusetts, United States.
Who are the decision-makers at Elevation Oncology?
Fundz holds 1 contact at Elevation Oncology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Elevation Oncology that raised within 45 days of this round, from Fundz verified event records.

  • Damora Therapeutics, Inc. raised $64M on November 5, 2020.
  • Lipella Pharmaceuticals raised $405K (Seed) on November 4, 2020.
  • Solid Biosciences raised $40M on October 26, 2020.
  • Definium Therapeutics raised $78K (Seed) on December 22, 2020.
  • OnKure Therapeutics, Inc. raised $47M on December 21, 2020.
  • TuHURA Biosciences raised $2.7M (Seed) on December 17, 2020.

Who to call at Elevation Oncology, and when

A new round usually means Elevation Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elevation Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elevation Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elevation Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elevation Oncology

Location

888 SEVENTH AVE

Boston, Massachusetts, United States

About

Elevation Oncology is founded on the belief that every patient living with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We aim to make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of tumor growth. Together with our peers, we work towards a future in which each tumor's unique genomic test result can be matched with a purpose-built precision medicine to enable an individualized treatment plan for each patient. Our most advanced candidate, seribantumab, is intended to inhibit tumor growth driven by NRG1 fusions and is currently being evaluated in the Phase 2 CRESTONE study for patients with solid tumors of any origin that have an NRG1 gene fusion. Details on CRESTONE are available at www.NRG1fusion.com. Our other product candidate, EO-3021, is a differentiated, clinical stage antibody drug conjugate that targets Claudin18.2 and is currently being developed for the treatment of genomically defined solid tumors. For more information, visit www.ElevationOncology.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elevation Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts4 people are listed at Elevation Oncology. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Elevation Oncology's next move

See what Strategic adds

Elevation Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.